Top 2 Health Care Stocks That May Rocket Higher This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

West Pharmaceutical Services Inc WST

On Feb. 13, West Pharmaceutical Services reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72. The designer and manufacturer of injectable pharmaceutical packaging and delivery systems reported sales of $748.8 million, beating the consensus of $740.47 million. The company's stock fell around 39% over the past month and has a 52-week low of $197.01.
RSI Value: 21.2
WST Price Action: Shares of West Pharmaceutical gained 2.6% to trade at $208.92 on Friday.
Benzinga Pro's real-time newsfeed alerted to latest WST news.

Amphastar Pharmaceuticals Inc AMPH

Amphastar Pharmaceuticals will release results for its fourth quarter results, after the market closes on Thursday, Feb. 27, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time. The company's stock fell around 13% over the past month and has a 52-week low of $30.34.
RSI Value: 25.3
AMPH Price Action: Shares of Amphastar Pharmaceuticals fell 0.8% to close at $120.92 on Wednesday.
Benzinga Pro’s charting tool helped identify the trend in AMPH stock.